Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Remmie
AddedFeb 15, 2024
UpdatedJun 18, 2026
Remmie

Remmie

Pre-Seed

Remmie, a smart otoscope manufacturer, empowers families and enhances telemedicine accuracy.

HQ
Culver City, CA, US
Founded
2018
Accelerator
Techstars logoTechstars: UnitedHealthcare2021
Overview
Compare
Fundraising
Employees
Website

Remmie, founded in 2018 and headquartered in Culver City, California, develops and manufactures smart, connected otoscopes designed to empower families and improve diagnostic accuracy for telemedicine companies. Their core mission is to enhance healthcare accessibility and accuracy by providing user-friendly medical devices that allow for home diagnostics and remote consultations. Remmie's flagship product, the Remmie 3, is an intelligent ear, nose, and throat scope that helps families avoid unnecessary trips to the doctor’s office.

Notable affiliated people include the founders and key investors who have supported Remmie's growth. The company has achieved significant milestones, including the successful launch of multiple product iterations and securing partnerships with telemedicine providers. Remmie's impact is evident in its contribution to reducing healthcare costs and improving patient outcomes through enhanced diagnostic tools.

Remmie - Similar Companies

Reemo logo

Reemo

reemohealth.com

HelpWear logo

HelpWear

helpwear.ca

TytoCare logo

TytoCare

tytocare.com

Steth IO logo

Steth IO

stethio.com

Remède logo

Remède

remedeco.com

Rezilient Health logo

Rezilient Health

Relief Telemed logo

Relief Telemed

relieftelemed.com

MedWand Solutions logo

MedWand Solutions

medwand.com

RemoteDoc logo

RemoteDoc

Reme-D. logo

Reme-D.

reme-d-inc.com

TeleMedicX logo

TeleMedicX

telemedicx.com

Rthm logo

Rthm

rthm.com

Octovis logo

Octovis

MedM logo

MedM

medm.com

Routinify logo

Routinify

Remmie - Quick Facts

Who are Remmie's competitors?

Companies similar to Remmie include Reemo, HelpWear, TytoCare and Steth IO.

When was Remmie founded?

Remmie was founded in 2018.

Where is Remmie's headquarters located?

Remmie's headquarters is located in Culver City, CA, US.

How much has Remmie raised to-date?

As of Nov 1, 2022, Remmie has raised a total of $120k (USD).

How many employees does Remmie have?

Remmie has 6 employees as of Feb 4, 2024.

Remmie - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Transactional
Customer
  • Consumers
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities